✦ LIBER ✦

Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder

✍ Scribed by Miho Watanabe; Tomonori Yamanishi; Mikihiko Honda; Ryuji Sakakibara; Tomoyuki Uchiyama; Ken-Ichiro Yoshida

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Safety, Tolerability and Effic

✍ K Kreder; C Mayne; U Jonas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 221 KB

A comparison of extended-release oxybuty

✍ Peter K. Sand; John Miklos; Henry Ritter; Rodney Appell 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 212 KB

Effectiveness and tolerability of extend

✍ Rodney U. Anderson; Scott MacDiarmid; Sherron Kell; James H. Barada; Scott Serel 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 137 KB

Long-term safety, tolerability and effic

✍ MINEO TAKEI; YUKIO HOMMA; THE JAPANESE TOLTERODINE STUDY GROUP 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Canadian economic comparison of extended

✍ Denis Getsios; J.Jaime Caro; K.Jack Ishak; Wissam El-Hadi; Krista Payne 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

The clinical efficacy of tolterodine ext

✍ Roger Dmochowski; Karl Kreder; Scott MacDiarmid; Martin Carlsson; Zhonghong Guan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB